Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGDCC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ROBO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
VAMP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC644135 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AMBRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF407 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929964 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIOBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ME1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF362 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on